 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- RCD405 / Respiratorius
Pharmacological characterization of the relaxant effect of RCD405 in isolated human small airways (PS-11; Poster board no. 14) - May 31, 2024 - Abstract #ERS2024ERS_3028;
Calzetta et al., Br J Pharmacol. 2024 Mar; 181:610-639.
- RCD405 / Respiratorius
Pharmacological characterization of the relaxant effect of RCD405 in isolated human medium bronchi (PS-10; Poster board no. 15) - May 31, 2024 - Abstract #ERS2024ERS_3007;
Calzetta et al., Br J Pharmacol. 2024 Mar; 181:610-639.
- | RCD405 / Respiratorius
Notice of allowance for patent application regarding RCD405 in the US https://t.co/97KnDS71VZ (Twitter) - Mar 14, 2023
- | RCD405 / Respiratorius
BioStock: Arcede Pharmas nye rådgivare om marknaden och RCD405 https://t.co/towRmR2o3B (Twitter) - Jan 31, 2023
- | RCD405 / Respiratorius
Japanska patentverket beviljar patent för RCD405 https://t.co/5N7OwIisDF (Twitter) - Nov 28, 2022
- | RCD405 / Respiratorius
BioStock: Arcede Pharmas RCD405 vältolererad https://t.co/ToDOUD74gO (Twitter) - Nov 27, 2022
- || RCD405 / Respiratorius
BioStock: Arcede Pharma’s RCD405 well tolerated https://t.co/S92OMM1L4U (Twitter) - Nov 27, 2022